N
Nuvectis Pharma, Inc. (NVCT)
NCM – Real Time Price. Currency in USD
7.48
-0.33 (-4.23%)
At close: Mar 27, 2026, 4:00 PM EDT
7.43
-0.05 (-0.63%)
After-hours: Mar 27, 2026, 5:48 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
7.48
-0.33 (-4.23%)
At close: Mar 27, 2026, 4:00 PM EDT
7.43
-0.05 (-0.63%)
After-hours: Mar 27, 2026, 5:48 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.38 | 6.05 | 10 | |
| Quick ratio | 2.38 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -19M | -23M | -20M | -28M | -28M |
| Net Income | -19M | -22M | -19M | -29M | -29M |
| EBITDA | -19M | -23M | -20M | -28M | -28M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -16.3 | 1.0 |
| Next quarter | N/A | -7.33 | 1.0 |
| Current year | N/A | 4.09 | 2.5 |
| Next year | N/A | -3.95 | 1.0 |
| Weighted average score | 1.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 26.05 | 29.55 | 11.57 | 9.3 |
| Y/Y | 999 | -17.05 | 11.43 | -61.21 | 4.8 |
| 3y average | 999 | -17.96 | 2.92 | -8.36 | 4.0 |
| 5y average | 999 | -25780.38 | 14.69 | 186.24 | 7.3 |
| Weighted average score | 6.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $31.6M barely cover the upcoming debt maturities $0.0
Total current assets $31.7M exceed Total current liabilities $13.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.0M limits the company's ability to reinvest or pay down debt